MedTrace Logo

An Analysis of the Symptomatic Domains Most Relevant to Charcot Marie Tooth Neuropathy (CMT) Patients

NCT02429947 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 411

Last updated 2017-06-14

No results posted yet for this study

Summary

The purpose of this study is to identify the issues that have greatest impact on QOL for patients with Charcot Marie Tooth (CMT) Disease. Patients who have -registered in the Inherited Neuropathies Consortium Contact Registry will be invited to participate.

Conditions

  • Charcot Marie Tooth Disease (CMT)
  • Hereditary Sensory and Motor Neuropathy
  • Nerve Compression Syndromes
  • Tooth Diseases
  • Congenital Abnormalities
  • Genetic Diseases, Inborn
  • Heredodegenerative Disorders, Nervous System

Sponsors & Collaborators

  • University of Rochester

    collaborator OTHER

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • University of South Florida

    lead OTHER

Principal Investigators

  • David Herrmann, MBBCh · University of Rochester

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02429947 on ClinicalTrials.gov